Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 020106 | MRE-269 | 475085-57-5 | 98% |  |
| MRE-269 is a long-acting and highly selective prostacyclin receptor agonist. | ||||
| 011906 | MSX-122 | 897657-95-3 | 98% |  |
| MSX-122 is a n orally bioavailable inhibitor of CXCR4 with potential antineoplastic a | ||||
| 011902 | ME-143 | 852536-39-1 | 98% |  |
| ME -143 is a derivative of triphendiol and is a highly potent, pan acting ant-cancer. | ||||
| 011805 | MK-2206 | 1032349-93-1 | 98% |  |
| MK-2206 2Hcl is an orally bioavailable allosteric inhibitor of the serine/threonine p | ||||
| 011801 | MK-8033 | 1001917-37-8 | 98% |  |
| MK8033 is a novel and specific dual ATP competitive c-Met/Ron inhibitor (IC50=1 nM Wt | ||||
| 011301 | ML324 | 1222800-79-4 | 98% |  |
| ML324 is a potent JMJD2 demethylase inhibitor with demonstrated antiviral activity. | ||||
| 011110 | MK-1775 | 955365-80-7 | 98% |  |
| MK-1775 is a potent and selective Wee1 inhibitor with IC50 of 5.2 nM; hinders G2 DNA | ||||
| 010806 | MK-2461 | 917879-39-1 | 98% |  |
| MK-2461 is a novel ATP-competitive multitargeted inhibitor of activated c-Met. | ||||
| 010606 | Medetomidine hydrochloride | 86347-15-1 | 98% |  |
| Medetomidine Hydrochloride is an agonist of adrenergic alpha-2 receptor, which is use | ||||
| 010424 | MK-2048 | 870005-19-9 | 98% |  |
| MK-2048 is a second generation integrase inhibitor, intended to be used against HIV i | ||||
| 51627 | MK7622 | 1227923-29-6 | 98% by HPLC |  |
| MK-7622isused as adjunctive therapy to acetylcholinesterase inhibitors (AChEIs) for t | ||||
| 123007 | MK-4827 | 1038915-60-4 | 98% |  |
| MK-4827 is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM; with grea | ||||
| 122949 | MK-0752 | 471905-41-6 | 98% |  |
| MK-0752 is a moderately potent -secretase inhibitor, which reduces A40 production wit | ||||
| 122819 | MK8745 | 885325-71-3 | 98% |  |
| MK-8745 is a novel Aurora-A specific inhibitor. MK8745 induced apoptotic cell death i | ||||
| 122217 | MK 886 | 118414-82-7 | 98% |  |
| MK 886 is a leukotriene antagonist. It may perform this by blocking the 5-lipoxygenas | ||||
| 122101 | ML216 | 1430213-30-1 | 98% |  |
| ML216 is a potent inhibitor of the DNA unwinding activity of BLM helicase; showing si | ||||
| 121508 | Masitinib | 790299-79-5 | 98% |  |
| Masitinib is a novel inhibitor for Kit and PDGFR/ with IC50 of 200 nM and 540 nM/800 | ||||
| 121504 | MK-5108 | 1010085-13-8 | 98% |  |
| MK-5108 is a highly selective Aurora A inhibitor with IC50 of 0.064 nM; 220- and 190- | ||||
| 121502 | Mandyphos SL-M004-1 | 494227-37-1 | 97% |  |
| Coming soon! | ||||
| 121425 | Marbofloxacin | 115550-35-1 | 98% |  |
| Marbofloxacin is a potent antibiotic of which depends upon its inhibition of DNA-gyra | ||||
| 120712 | Micafungin sodium | 208538-73-2 | 98% |  |
| Micafungin is an antifungal drug that belongs to the antifungal class of compounds kn | ||||
| 120703 | Memantine hydrochloride | 41100-52-1 | 98% |  |
| Coming soon! | ||||
| 5112803 | 1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-ol | 924909-16-0 | 98% by HPLC at 254nm | -1H-pyrazolo[34-b]pyridin-4-ol-cas-924909-16-0.png) |
| 1-(4-methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-ol | ||||
| 111305 | MCB-613 | 1162656-22-5 | 98% |  |
| Coming soon! | ||||
| 111303 | MG-132 | 133407-82-6 | 98% |  |
| MG-132 is an inhibitor of proteasome with IC50 of 100 nM, and also inhibits calpain w | ||||
| 111015 | Mocetinostat(MGCD0103) | 726169-73-9 | 98% by HPLC/HNMR | -cas-726169-73-9.png) |
| Mocetinostat is an orally-bioavailable, spectrum-selective HDAC inhibitor. Mocetinost | ||||
| 111013 | MGCD-265-analog | 875337-44-3 | ≧98.0% |  |
| MGCD-265-analog is a tyrosine kinase inhibitor that selectively targets MET and Axl.M | ||||
| 102610 | MDL 28170 | 88191-84-8 | 98% |  |
| MDL 28170 is a potent, cell-permeable, and selective inhibitor of calpain and catheps | ||||
| 102207 | MI-773 | 1303607-60-4 | 98% |  |
| MI-773 is an orally available spiro-oxindole HDM2 (human double minute 2) antagonist | ||||
| 101915 | MK-0822 | 603139-19-1 | 98% |  |
| MK-0822 is an inhibitor of cathepsin K with potential anti-osteoporotic activity. It | ||||